BAM Management

Latest statistics and disclosures from BAM Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ONTY, BPAX, Genvec Inc, RXII, and represent 100.00% of BAM Management's stock portfolio.
  • Added to shares of these 3 stocks: ONTY, BPAX, Genvec Inc.
  • Reduced shares in these 1 stocks: RXII.
  • BAM Management was a net buyer of stock by $5.21M.
  • BAM Management has $12.95M in assets under management (AUM), growing by 20.96%.

Companies in the BAM Management portfolio as of September 2011 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Oncothyreon (ONTY) 57.60 1.25M +66% 5.98
BioSante Pharmaceuticals (BPAX) 38.60 2.19M +89% 2.28
Genvec Inc 2.42 109024 +20% 2.87
RXi Pharmaceuticals Corporation (RXII) 1.38 177406 -51% 1.01

Past 13F-HR SEC Filings by BAM Management

View All Filings